ℹ️
🇬🇧
Search
Search for people relevant for "Relapsed/refractory"
Relapsed/refractory
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Jana Marková
Academic staff at Third Faculty of Medicine
52 publications
Publications
publication
Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia
2019 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Hodgkin lymphoma - hendless story Hodgkin lymphoma - endless story
2019 |
Third Faculty of Medicine
publication
Treatment and Prognosis of Relapsed or Refractory Hodgkin Lymphoma Patients Ineligible for Stem Cell Transplantation
2014 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma
2011 |
Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Treatment of patients with relapsed/refractory Hodgkin lymphoma
2011 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic
2023 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced stage Hodgkin Lymphoma: results from the randomized international GHSG HD18 trial
2023 |
Third Faculty of Medicine
publication
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)
2021 |
Third Faculty of Medicine
publication
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
2021 |
Third Faculty of Medicine